International Biotechnology (LON:IBT) Shares Pass Above 200 Day Moving Average – Should You Sell?

International Biotechnology (LON:IBT) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 988.11 and traded as high as GBX 1,128.99. International Biotechnology shares last traded at GBX 1,120, with a volume of 184,369 shares changing hands.

International Biotechnology Trading Down 0.9%

The business has a fifty day simple moving average of GBX 1,079.31 and a 200-day simple moving average of GBX 988.11. The company has a debt-to-equity ratio of 9.43, a quick ratio of 0.32 and a current ratio of 0.11. The firm has a market cap of £356.19 million, a price-to-earnings ratio of 4.63 and a beta of 0.47.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.